New Releases from NCBI BookshelfBrentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma.Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma.
Post Content
The key role of medical workforce well-being in the delivery of excellent and equitable care is recognised internationally. However, doctors
Post Content